Having trouble accessing articles? Reset your cache.

Syntrix analgesic overcomes tramadol’s dependence on CYP2D6

Syntrix is creating desmetramadol as a safer and less variable version of tramadol

Bypassing the metabolic conversion required for Schedule IV opiate tramadol to achieve analgesia, Syntrix has positioned desmetramadol as a safer and more effective pain therapy.

Tramadol has been positioned as less likely to cause lethal respiratory depression than other opioids,

Read the full 392 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE